Gilead Sciences, Inc.GILD
Price as of · delayed, not real-time
A biopharmaceutical company focused on antiviral therapies, oncology, and cell therapy, with a leading portfolio in HIV treatment and prevention. Revenue is driven primarily by its HIV franchise, alongside growing contributions from oncology and liver disease products. Investors track the company for its patent cycle management, pipeline development, and capital allocation strategy, including acquisitions and share repurchases.
Congressional Interest in Gilead Sciences, Inc. (GILD)
14 members of Congress have disclosed 360 trades in Gilead Sciences, Inc. (GILD), a Healthcare company. The buy/sell breakdown shows 27 purchases versus 23 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Who in Congress Is Trading GILD?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-07-20 | Rohit Khanna | buy | $1K-$15K |
| 2026-07-07 | Rohit Khanna | sell | $1K-$15K |
| 2026-06-16 | Rohit Khanna | sell | $1K-$15K |
| 2026-05-15 | Rohit Khanna | buy | $1K-$15K |
| 2026-05-06 | Jared Moskowitz | buy | $1K-$15K |
| 2026-05-06 | Jared Moskowitz | buy | $1K-$15K |
| 2026-04-13 | Rohit Khanna | sell | $15K-$50K |
| 2026-03-27 | Alan Armstrong | buy | $1K-$15K |
| 2026-01-29 | Rohit Khanna | buy | $1K-$15K |
| 2026-01-27 | Josh Gottheimer | buy | $1K-$15K |
| 2026-01-23 | Rohit Khanna | buy | $1K-$15K |
| 2025-09-25 | Rohit Khanna | sell | $1K-$15K |
| 2025-09-23 | Rohit Khanna | buy | $1K-$15K |
| 2025-09-23 | Valerie Hoyle | sell | $1K-$15K |
| 2025-09-05 | Rohit Khanna | buy | $1K-$15K |
| 2025-06-06 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-05-14 | Josh Gottheimer | sell | $1K-$15K |
| 2025-05-12 | Jefferson Shreve | sell | $15K-$50K |
| 2025-05-05 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-05-05 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2025-04-16 | John Boozman | sell | $1K-$15K |
| 2025-03-31 | Jefferson Shreve | buy | $15K-$50K |
| 2025-03-10 | Carol Devine Miller | buy | $1K-$15K |
| 2025-03-07 | Josh Gottheimer | buy | $1K-$15K |
| 2024-12-24 | Marjorie Taylor Greene | buy | $1K-$15K |
| 2024-11-13 | MICHAEL T. MCCAUL | sell | $1K-$15K |
| 2024-10-29 | Valerie Hoyle | buy | $1K-$15K |
| 2024-08-10 | Rohit Khanna | sell | $1K-$15K |
| 2024-08-05 | Rohit Khanna | sell | $1K-$15K |
| 2024-08-02 | Rohit Khanna | sell | $1K-$15K |
| 2024-05-29 | Rohit Khanna | buy | $1K-$15K |
| 2024-04-26 | Rohit Khanna | sell | $1K-$15K |
| 2024-04-05 | Thomas H Tuberville | buy | $1K-$15K |
| 2024-04-03 | Thomas H Tuberville | sell | $1K-$15K |
| 2024-03-25 | Rohit Khanna | buy | $1K-$15K |
| 2024-02-13 | Rohit Khanna | buy | $1K-$15K |
| 2023-12-05 | Rohit Khanna | buy | $1K-$15K |
| 2023-11-05 | Rohit Khanna | sell | $1K-$15K |
| 2023-10-24 | Greg Stanton | sell | $1K-$15K |
| 2023-10-02 | Rohit Khanna | buy | $1K-$15K |
| 2023-09-26 | Greg Stanton | buy | $1K-$15K |
| 2023-08-29 | Rohit Khanna | sell | $1K-$15K |
| 2023-07-28 | Rohit Khanna | sell | $1K-$15K |
| 2023-07-12 | Daniel Goldman | sell | $15K-$50K |
| 2023-05-25 | ZOE LOFGREN | sell | $1K-$15K |
| 2023-03-06 | Daniel Goldman | buy | $15K-$50K |
| 2023-01-09 | Rohit Khanna | sell | $1K-$15K |
| 2022-09-09 | ZOE LOFGREN | buy | $1K-$15K |
| 2022-05-02 | Rohit Khanna | sell | $1K-$15K |
| 2022-01-13 | Thomas H Tuberville | sell | $1K-$15K |